Dyslipidemia in the Russian Federation: population data, associations with risk factors

Dyslipidemia in the Russian Federation: population data, associations with risk factors

Aim. To study the prevalence of dyslipidemias and their association with various risk factors in the Russian population of men and women aged 35-74 years in 2020-2022.Material and methods. This work was carried out as part of the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regi...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. M. Drapkina, A. E. Imaeva, V. A. Kutsenko, A. V. Kapustina, Yu. A. Balanova, S. A. Maksimov, G. A. Muromtseva, M. B. Kotova, N. S. Karamnova, S. E. Evstifeeva, O. A. Litinskaya, M. S. Pokrovskaya, N. A. Imaeva, E. M. Filichkina, O. E. Ivlev, G. E. Svinin, L. I. Gomanova, Yu. V. Doludin, I. A. Efimova, A. L. Borisova, B. M. Nazarov, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, V. S. Shramko, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, A. A. Keskinov, V. S. Yudin, S. M. Yudin, A. V. Kontsevaya, S. A. Shalnova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2023-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	dyslipidemia total cholesterol low-density lipoprotein cholesterol high-density lipoprotein cholesterol triglycerides lipid profile russian population
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3791
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
by: G. P. Arutyunov, et al.
Published: (2022-09-01)

Use of polygenic risk scores for differential diagnostics for patients with clinical diagnosis of familial hypercholesterolemia
by: M. Zaychenoka, et al.
Published: (2025-02-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders
by: S. A. Shalnova, et al.
Published: (2022-09-01)

Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry
by: I. A. Alekseeva, et al.
Published: (2025-08-01)

Disorders of lipid metabolism. Clinical Guidelines 2023
by: M. V. Ezhov, et al.
Published: (2023-06-01)

Effect of phytocomposition on dyslipidemia in patients with SARS-CoV-2 infection at the health resort stage of treatment
by: I. A. Yatskov, et al.
Published: (2025-03-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
by: A. N. Meshkov, et al.
Published: (2022-11-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now
by: S. A. Shalnova, et al.
Published: (2024-12-01)

Genetic aspects of decreased low-density lipoprotein cholesterol values
by: A. N. Meshkov, et al.
Published: (2023-12-01)

Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
by: O. A. Koshelskaya, et al.
Published: (2020-03-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)
by: R. G. Oganov, et al.
Published: (2012-08-01)

Combined lipid lowering therapy, including ezetimibe, in the post-infarction period
by: V. E. Oleynikov, et al.
Published: (2024-05-01)

METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS
by: N. V. Perova, et al.
Published: (2016-01-01)

Associations of changes in lipid metabolism parameters and the severity of COVID-19 infection in Novosibirsk residents
by: A. A. Karaseva, et al.
Published: (2022-09-01)

Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations
by: Z. F. Kim, et al.
Published: (2024-02-01)

AWARENESS AND TREATMENT SPECIFICS OF STATIN THERAPY IN PERSONS WITH VARIOUS CARDIOVASULAR RISK: THE STUDY ESSE-RF
by: S. A. Shalnova, et al.
Published: (2016-08-01)

Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen levels
by: A. V. Susekov, et al.
Published: (2006-12-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

Analysis of risk factors for aortic stenosis in patients with familial hypercholesterolemia
by: V. A. Korneva, et al.
Published: (2025-02-01)

Cholesterol of Low-Density Lipoprotein-Containing Circulating Immune Complexes Improves Prognosis of Asymptomatic Carotid Atherosclerosis
by: A. N. Orekhov, et al.
Published: (2024-06-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)

Association of Lipid Profile with Body Mass Index in Public Employees in Halabja City, Kurdistan Region of Iraq
by: Hardi R. Baqi, et al.
Published: (2020-06-01)

DISTRIBUTION OF LIPID PROFILE VALUES IN ECONOMICALLY ACTIVE MEN AND WOMEN IN RUSSIAN FEDERATION: RESULTS OF THE ESSE-RF STUDY FOR THE YEARS 2012-2014
by: A. N. Meshkov, et al.
Published: (2017-08-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01)

Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)

The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)
by: K. S. Astrakova (Benimetskaya), et al.
Published: (2025-01-01)

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
by: I. V. Sergienko, et al.
Published: (2023-12-01)

Visceral obesity in patients with various body mass index
by: S. V. Miklisanskaya, et al.
Published: (2021-06-01)

Lipid-lowering therapy: modern possibilities and real clinical practice
by: A. V. Blokhina, et al.
Published: (2022-09-01)

CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)
by: S. A. Boytsov, et al.
Published: (2013-08-01)

SURVIVAL FUNCTIONS IN 40-59 YEAR OLD MALE COHORTS ACCORDING TO THE PRESENCE OF ARTERIAL HYPERTENSION AND/OR MYOCARDIAL INFARCTION AND VARIOUS HIGH DENSITY LIPOPROTEIDES CONCENTRATIONS (BY THE 30-YEARS OBSERVATION)
by: V. V. Belov, et al.
Published: (2014-10-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)